You're cordially invited to our exclusive dinner program tailored for oncology trainees, physicians, advanced practice providers, and affiliated health professionals.
This event promises to be an enlightening and enriching experience, offering valuable insights into the latest developments and initiatives undertaken by the American Society of Clinical Oncology (ASCO) for the benefit of both oncology professionals and patients alike including why your voice matters.
.png)
Please note, this gathering is exclusively for oncology healthcare professionals, and no pharmaceutical or MSL representatives will be in attendance unless specifically invited.
During the dinner program, we are privileged to have esteemed ASCO Board of Director members, Ann H. Partridge, MD, MPH, FASCO and Jennifer Temel, MD, FASCO as our speakers. They will delve into the significant contributions and ongoing efforts of ASCO in enhancing the practice of oncology care, focusing on how these initiatives directly impact us as professionals and, most importantly, benefit our patients.
Speakers
Ann H. Partridge, MD, MPH, FASCO
Eric P. Winer, MD, Chair in Breast Cancer Research
Vice Chair, Department of Medical Oncology
Director, Adult Survivorship Program
Director, Program for Young Women with Breast Cancer
Professor of Medicine, Harvard Medical School
Dr. Partridge is a practicing medical oncologist and clinical researcher. She is vice chair of the Department of Medical Oncology at Dana-Farber Cancer Institute, where she also serves as director of the Adult Survivorship Program and co-founder and director of the Program for Young Women with Breast Cancer. As a professor at Harvard Medical School, Dr. Partridge holds the Eric P. Winer, MD Chair in Breast Cancer Research at Dana-Farber. She leads clinical research and educational efforts nationally and internationally, and is particularly committed to improving outcomes for young women with breast cancer. Dr. Partridge serves on the Board of Directors of the American Society of Clinical Oncology (ASCO), co-chairs the National Cancer Institute (NCI) Alliance for Clinical Trials in Oncology Breast Committee, and serves on the NCI Breast Cancer Steering Committee. She is Chief Scientific Advisor for Susan G. Komen, and her research has been supported by the NCI, Breast Cancer Research Foundation (BCRF), Conquer Cancer, and Susan G. Komen. Dr. Partridge has received a Champions of Change award from the U.S. White House, the American Association for Clinical Research (AACR) Outstanding Investigator Award for Breast Cancer, and ASCO’s Ellen L. Stovall Award for Advancement of Cancer Survivorship Care.
Jennifer M. Temel, MD, FASCO
Dr. Jennifer Temel is the co-Director of the Cancer Outcomes Research and Education Program and Clinical Director of Thoracic Oncology at the Massachusetts General Hospital Cancer Center and Professor of Medicine at Harvard Medical School. Her research focuses on improving the experience and outcomes of patients with serious cancers and their family members.
